Real-world evidence (RWE) empowers payers and providers to make more informed, cost-effective treatment. Read more here: ...

This year, sales of Eliquis (apixaban) are projected to decline by 15.2% due to the loss of its European market exclusivity ...

Lilly and German biotech Seamless Therapeutics will develop recombinase-based treatments for hearing loss. In a move that ...

Insilico Medicine has entered a strategic partnership with Qilu Pharmaceutical to develop treatments for cardiometabolic ...

Ocado is adapting its advanced grocery fulfilment technology for pharmaceutical warehousing. Here's what it wants to achieve.

The 15 drugs accounted for $27bn in spending via Medicare Part B and Part D between November 2024 and October 2025.

Other countries in Europe to lose eliminated status include Armenia, Austria, Azerbaijan, Spain, and Uzbekistan. Sustained ...

The two companies reportedly could not agree on a price, leaving pharma’s first potential megadeal of 2026 on ice.

The lack of initial public offerings (IPOs) also reflects a year of restricted growth. As per the BIA, no UK biotechs went ...

A new report has revealed that 83% of life sciences CEOs view Internet of Medical Things (IoMT) devices as the most important capability towards driving growth, accelerating R&D, and unlocking ...

Bristol Myers Squibb (BMS) has entered into an agreement with Microsoft to advance AI-driven early lung cancer detection.